Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL719011 | 1.00 | SIGMAR1 (0.74) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| SCHEMBL2795948 | 1.00 | SIGMAR1 (0.74) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| SCHEMBL593666 | 1.00 | SIGMAR1 (0.74) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| Hydrochloric Acid SCHEMBL1134234 | 0.98 | SIGMAR1 (0.72) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| Hydrochloric Acid SCHEMBL1134233 | 0.98 | SIGMAR1 (0.72) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| SCHEMBL3341840 | 0.92 | SIGMAR1 (0.62) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| SCHEMBL3341844 | 0.92 | SIGMAR1 (0.62) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| SCHEMBL3346880 | 0.92 | SIGMAR1 (0.62) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| SCHEMBL6539539 | 0.89 | SIGMAR1 (0.59) | SIGMAR1MEN1KMT2AL3MBTL1SLC2A1 | |
| SCHEMBL3630860 | 0.88 | SIGMAR1 (0.57) | SIGMAR1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057371-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0591426-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1994-04-13 | — | — | EP | disclosed |
| EP-0507863-A4 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | — | 1993-07-07 | — | — | EP | disclosed |
| WO-1993000313-A2 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1993-01-07 | — | — | WO | disclosed |
| EP-0507863-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1992-10-14 | — | — | EP | disclosed |
| WO-1991009594-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1991-07-11 | — | — | WO | disclosed |